Eleven Biotherapeutics misses by $0.06, beats on revenue

|About: Eleven Biotherapeutics,... (EBIO)|By:, SA News Editor

Eleven Biotherapeutics (NASDAQ:EBIO): Q2 EPS of -$0.51 misses by $0.06.

Revenue of $0.8M (+300.0% Y/Y) beats by $0.7M.